• About us
• Contact

Advertisement

Organisation › Details

Roche Diagnostics (Group Division)

About Roche and the Roche Diagnostics Division

Headquartered in Basel, Switzerland, Roche is one of the world's leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. As a supplier of innovative products and services for the early detection, prevention, diagnosis and treatment of disease, the group contributes on a broad range of fronts to improving people's health and quality of life. Roche is a world leader in diagnostics, the leading supplier of medicines for cancer and transplantation and a market leader in virology.

In 2005 sales by the Pharmaceuticals Division totaled 27.3 billion Swiss francs, and the Diagnostics Division posted sales of 8.2 billion Swiss francs. Roche employs roughly 70,000 people in 150 countries and has R&D agreements and strategic alliances with numerous partners, including majority ownership interests in Genentech and Chugai. Roche's Diagnostics Division offers a uniquely broad product portfolio and supplies a wide array of innovative testing products and services to researchers, physicians, patients, hospitals and laboratories world-wide. For further information, please visit our websites www.roche.com and www.roche-diagnostics.com *

 

	Start	2002-12-17
	Group	Roche (Group)
	Industry	diagnostics (medical/biological)
	Industry 2	PCR technology
	Region	Indianapolis, IN
	Country	United States (USA)
	Street	9115 Hague Road
	City	46250-0457 Indianapolis, IN
		Address record changed: 2020-12-02
Basic data	Employees	n. a.
	Currency	CHF
	Annual sales	9,300,000,000 (sales (Divisional 2007) 2008-03-13)
		* Document for »About Section«:
		Record changed: 2025-06-22

Advertisement

More documents for Roche (Group)

• [1] OMass Therapeutics Ltd.. (9/2/25). "Press Release: OMass Therapeutics Enters into Exclusive Collaboration and License Agreement with Genentech to Develop and Commercialize Therapies for Inflammatory Bowel Disease". Oxford....
• [2] Roche. (12/18/24). "Press Release: Roche Transforms Mass Spectrometry Diagnostics with Launch of cobas Mass Spec Solution". Basel....
• [3] Roche. (12/29/23). "Press Release: Roche Enters into a Definitive Agreement to Acquire LumiraDx's Point of Care Technology Combining Multiple Diagnostic Modalities on a Single Platform". Basel....
• [4] NanoTemper Technologies GmbH. (5/18/22). "Press Release: NanoTemper Technologies Welcomes Andreas Schmitz as Its First Chief Human Resources Officer". Munich....
• [5] Agilent Technologies Inc.. (1/15/21). "Press Release: Agilent Names Allison Ballmer Senior Vice President of Corporate Development". Santa Clara, CA....
• [6] Genedata AG. (3/10/20). "Press Release: Chugai Implements Genedata Profiler to Accelerate Data-driven Biomarker Discovery". Tokyo....
• [7] Merck KGaA [Merck Millipore]. (1/14/19). "Press Release: Merck and Roche Renew Global Distribution Agreement"....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.